BSE Live
Oct 17, 16:01Prev. Close
307.55
Open Price
309.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Profit & Loss account of Samrat Pharmachem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 285.86 | 281.58 | 310.65 | 253.95 | 204.33 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 32.20 | 25.35 | |
Revenue From Operations [Net] | 285.86 | 281.58 | 310.65 | 221.75 | 178.98 | |
Total Operating Revenues | 285.86 | 281.58 | 310.65 | 221.81 | 179.02 | |
Other Income | 0.97 | 1.38 | 0.48 | 0.55 | 0.46 | |
Total Revenue | 286.83 | 282.97 | 311.12 | 222.36 | 179.48 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 269.27 | 265.48 | 288.00 | 190.23 | 162.02 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 0.00 | 3.58 | 4.01 | 3.77 | 2.86 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -2.52 | 4.84 | -10.14 | -0.33 | 2.23 | |
Employee Benefit Expenses | 2.22 | 2.22 | 1.88 | 1.77 | 1.50 | |
Finance Costs | 0.67 | 0.69 | 1.23 | 0.67 | 1.28 | |
Depreciation And Amortisation Expenses | 0.65 | 0.65 | 0.64 | 0.59 | 0.49 | |
Other Expenses | 6.65 | 2.99 | 2.96 | 2.03 | 1.74 | |
Total Expenses | 276.95 | 280.45 | 288.59 | 198.74 | 172.12 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 9.89 | 2.52 | 22.53 | 23.62 | 7.36 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | |
Profit/Loss Before Tax | 9.89 | 2.52 | 22.53 | 23.60 | 7.34 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 2.77 | 0.20 | 6.16 | 6.38 | 1.72 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 0.08 | -0.21 | 0.03 | 0.29 | |
Tax For Earlier Years | 0.00 | 0.07 | -0.05 | 0.01 | 0.00 | |
Total Tax Expenses | 2.77 | 0.36 | 5.90 | 6.42 | 2.01 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 7.11 | 2.16 | 16.63 | 17.18 | 5.33 | |
Profit/Loss From Continuing Operations | 7.11 | 2.16 | 16.63 | 17.18 | 5.33 | |
Profit/Loss For The Period | 7.11 | 2.16 | 16.63 | 17.18 | 5.33 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 23.02 | 7.00 | 53.83 | 55.62 | 17.26 | |
Diluted EPS (Rs.) | 23.02 | 7.00 | 53.83 | 55.62 | 17.26 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.31 | 0.31 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 10.00 | 10.00 | 10.00 | 10.00 | 0.00 |
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y